NCT05879211Enrolling by invitation
Goal Concordant Care Learning Laboratory
Palliative Care Learning Laboratory
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 5000 (estimated)
- First submitted
- 14 May 2023
- Start date
- 12 Jul 2023
- Primary completion date
- Dec 2026
- Lead sponsor
- Duke University
- Diseases
- Heart failure, COPD
- NCT number
- NCT05879211
What you commit to
- Study type: Interventional
- Planned participants: 5000
- From 12 Jul 2023 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Duke Health patient
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke Health Coordinator of this site? Confirm its status | Durham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.